Assenagon Asset Management S.A. Decreases Stock Holdings in DocuSign, Inc. (NASDAQ:DOCU)

Assenagon Asset Management S.A. cut its position in DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 78.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 46,873 shares of the company's stock after selling 168,004 shares during the quarter. Assenagon Asset Management S.A.'s holdings in DocuSign were worth $2,787,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in DOCU. Executive Wealth Management LLC acquired a new stake in shares of DocuSign in the third quarter valued at approximately $1,000,000. SG Americas Securities LLC increased its holdings in shares of DocuSign by 93.1% in the fourth quarter. SG Americas Securities LLC now owns 78,423 shares of the company's stock valued at $4,662,000 after purchasing an additional 37,801 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of DocuSign by 77.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,215,650 shares of the company's stock valued at $51,057,000 after purchasing an additional 531,682 shares during the period. Grimes & Company Inc. acquired a new stake in shares of DocuSign during the 3rd quarter worth about $12,047,000. Finally, Duality Advisers LP bought a new stake in shares of DocuSign during the 3rd quarter worth about $1,686,000. 77.64% of the stock is currently owned by institutional investors and hedge funds.

DocuSign Trading Up 3.3 %

DOCU traded up $1.96 on Wednesday, reaching $60.55. The stock had a trading volume of 2,203,760 shares, compared to its average volume of 3,730,503. The company has a market capitalization of $12.44 billion, a price-to-earnings ratio of 168.20, a price-to-earnings-growth ratio of 5.09 and a beta of 0.89. DocuSign, Inc. has a fifty-two week low of $38.11 and a fifty-two week high of $64.76. The firm has a 50-day moving average of $55.66 and a 200-day moving average of $50.76.

DocuSign (NASDAQ:DOCU - Get Free Report) last posted its earnings results on Thursday, March 7th. The company reported $0.15 earnings per share for the quarter, topping analysts' consensus estimates of $0.09 by $0.06. DocuSign had a net margin of 2.68% and a return on equity of 13.91%. The firm had revenue of $712.39 million for the quarter, compared to analyst estimates of $698.05 million. Sell-side analysts anticipate that DocuSign, Inc. will post 0.86 EPS for the current fiscal year.

Insider Transactions at DocuSign

In other DocuSign news, CEO Allan C. Thygesen sold 7,680 shares of the firm's stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $61.27, for a total transaction of $470,553.60. Following the completion of the transaction, the chief executive officer now owns 111,767 shares in the company, valued at approximately $6,847,964.09. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other DocuSign news, CEO Allan C. Thygesen sold 7,680 shares of the company's stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $61.27, for a total transaction of $470,553.60. Following the sale, the chief executive officer now owns 111,767 shares of the company's stock, valued at $6,847,964.09. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Teresa Briggs sold 499 shares of DocuSign stock in a transaction dated Thursday, February 29th. The stock was sold at an average price of $52.99, for a total value of $26,442.01. Following the completion of the transaction, the director now directly owns 6,169 shares of the company's stock, valued at $326,895.31. The disclosure for this sale can be found here. Insiders sold 39,871 shares of company stock worth $2,276,199 over the last ninety days. 17.80% of the stock is owned by insiders.

Analyst Ratings Changes

DOCU has been the subject of several research reports. JMP Securities reissued a "market outperform" rating and set a $84.00 price target on shares of DocuSign in a report on Monday, January 22nd. TheStreet upgraded shares of DocuSign from a "d+" rating to a "c-" rating in a research note on Tuesday, December 19th. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $50.00 price target on shares of DocuSign in a research report on Friday, January 12th. Morgan Stanley raised shares of DocuSign from an "underweight" rating to an "equal weight" rating and boosted their price objective for the company from $49.00 to $64.00 in a report on Tuesday, January 16th. Finally, Wells Fargo & Company lowered their target price on shares of DocuSign from $55.00 to $45.00 and set an "underweight" rating on the stock in a report on Monday, February 5th. Three research analysts have rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $58.33.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides DocuSign e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.